Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Cash from Financing Activities (2021 - 2025)

Historic Cash from Financing Activities for Qiagen (QGEN) over the last 11 years, with Q4 2025 value amounting to -$478.0 million.

  • Qiagen's Cash from Financing Activities rose 224.95% to -$478.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$178.6 million, marking a year-over-year increase of 5772.33%. This contributed to the annual value of -$179.0 million for FY2025, which is 5767.85% up from last year.
  • Per Qiagen's latest filing, its Cash from Financing Activities stood at -$478.0 million for Q4 2025, which was up 224.95% from $614.1 million recorded in Q3 2025.
  • In the past 5 years, Qiagen's Cash from Financing Activities registered a high of $614.1 million during Q3 2025, and its lowest value of -$489.0 million during Q4 2024.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$52.0 million (2021), whereas its average is -$53.7 million.
  • In the last 5 years, Qiagen's Cash from Financing Activities surged by 63744.25% in 2022 and then plummeted by 601250.0% in 2024.
  • Qiagen's Cash from Financing Activities (Quarter) stood at -$150.0 million in 2021, then increased by 16.0% to -$126.0 million in 2022, then soared by 93.65% to -$8.0 million in 2023, then crashed by 6012.5% to -$489.0 million in 2024, then rose by 2.25% to -$478.0 million in 2025.
  • Its Cash from Financing Activities stands at -$478.0 million for Q4 2025, versus $614.1 million for Q3 2025 and -$28.0 million for Q2 2025.